ClinicalTrials.Veeva

Menu

A Cost Effectiveness Analysis of Robotic Versus Laparoscopic Distal Pancreatectomy

F

Fundación de investigación HM

Status

Completed

Conditions

Surgery

Treatments

Device: Da Vinci

Study type

Observational

Funder types

Other

Identifiers

NCT03989739
Fundacionhm

Details and patient eligibility

About

This is a clinical and cost-effectiveness analysis within a retrospective comparative study of RDP and LDP conducted at Sanchinarro University Hospital from 2011 to 2017. Outcome parameters included surgical and post-operative costs, quality adjusted life years (QALY), and incremental cost per QALY gained or the incremental cost effectiveness ratio (ICER). A sensitivity analysis was carried out in order to propagate the uncertainty of the estimations to the results of the model. The investigators use a multivariate and stochastic sensitivity analysis performed by 5000 Monte Carlo simulations. The cost-effectiveness plane was used to represent all pairs of solutions of the model.

Enrollment

59 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients (aged over 18 years) with benign or malignant mass without evidence of major vessel involvement were included.
  • The indication for resection was given in the context of a multidisciplinary institutional committee

Exclusion criteria

Trial design

59 participants in 2 patient groups

robotic distal pancreatectomy
Treatment:
Device: Da Vinci
laparoscopic distal pancreatectomy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems